Thermo Fisher lifts profit forecast as biotech demand shows signs of improvement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Thermo Fisher Scientific (TMO) PT Raised to $655 at Jefferies
July 24, 2024 4:04 PM EDTJefferies analyst Brandon Couillard raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $655.00 (from $650.00) while maintaining a Buy rating.
The analyst comments "TMO delivered solid revenue/EPS upside despite the still choppy demand backdrop. FY guidance was nudged... More
Thermo Fisher Scientific (TMO) PT Raised to $664 at RBC Capital, 'Recovery on Track'
July 24, 2024 12:39 PM EDTRBC Capital analyst Conor McNamara raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $664.00 (from $660.00) while maintaining a Outperform rating.
The analyst comments "Since taking over as the leader of TMO in 2009, CEO Marc Caspar (by our math) has hit or... More
Goldman Sachs Reiterates Buy Rating on Thermo Fisher Scientific (TMO)
July 24, 2024 7:15 AM EDTGoldman Sachs analyst Matthew Sykes reiterated a Buy rating and $650.00 price target on Thermo Fisher Scientific (NYSE: TMO).
The analyst comments "2Q24 bottom line beat with (1%) in organic growth: 2Q revenue of $10.54bn is above Visible Alpha Consensus Data of $10.52bn... More
